Breast Cancer Survivorship, 1st ed. 2016 Consequences of early breast cancer and its treatment

This book discusses the impact on women of the diagnosis and treatment of early breast cancer. Readers will learn about the risks of breast cancer recurrence and interventions to reduce these, such as endocrine therapy and bisphosphonate therapy, as well as the role of lifestyle factors such as diet and exercise. The long-term effects of treatment on fertility, the heart and other systems are discussed, as well the  psychological burden for women who are increasingly likely to be cured from their cancer.  Each chapter provides background and a  practical guide in the management of women after the initial phase of diagnosis and treatment.

From oncologists to general practitioners as well as specialist nurses, gynaecologists, psychologists and other healthcare professionals  involved in the long-term care of women with breast cancer, this book provides a timely and indispensable guide to practitioners caring for early breast cancer survivors.

1. Introduction

David Okonji and Alistair Ring

PART 1: DISEASE RECURRENCE

2 Predicting Risk of Disease Recurrence

Belinda Yeo

3 Detection of Recurrence: Clinical Follow-Up

Anne Mc Loughlin and Nicola Roche

4 Detection of Recurrence: Imaging Strategies

Kate Downey and Steven Allen

5 Follow Up of Patients with Germline Mutations in High Risk Predisposition Genes<

Zoe Kemp

PART 2: INTERVENTIONS TO REDUCE RISK OF RECURRENCE

6 Endocrine Therapy

Stefania Redana

7 Systemic Therapies to Reduce the Risk of Recurrence in Early Breast Cancer: New Strategies

Narda Chaabouni, Christos  Nikolaou and Mark Harries

8 Exercise in Breast Cancer Survivors

Nawa Mustafa Amin and Alistair Ring

9 Dietary Components and Breast Cancer Survivorship

Clare Shaw

PART 3: SEQUELAE OF EARLY BREAST CANCER AND ITS TREATMENT

10 Identifying and Managing the Consequences of Treatment for Early Breast Cancer

Natalie Doyle, Nicola Cunningham, and Richard Henry

11 Managing Loco-Regional Complications of Breast Cancer Treatment

Anna M. Kirby

12 The Role of Surgery in Breast Cancer Survivors

Rachel L. O’Connell and Jennifer E. Rusby

13 Management of Menopausal Symptoms in Breast Cancer Survivors

Helen Mitchell and Anne C. Armstrong

14 Bone Health

Amy Kwan, Omar S. Din, and Matthew Winter

15 Fertility

Stuart Lavery and Georgios Christopoulos

16 Cardiotoxicity in Breast Cancer Survivors

Nilesh Pareek, Susannah Stanway, Anna M. Kirby, and Alexander Lyon

17 Second Primary Neoplasms Following a Diagnosis of Breast Cancer

Felicity Paterson, Susannah Stanway, Lone Gothard, and Navita Somaiah

18 The Effects of Breast Cancer Treatments on Cognition

Helena Harder and Valerie A. Jenkins

19 Psychological Issues in Breast Cancer Survivorship

Richard Towers

20 Fatigue in Breast Cancer Survivors

Belinda Kingston and Marta Capelan

Dr Ring is a consultant in medical oncology at the Royal Marsden Hospital. He undertook his pre-clinical training at the University of Cambridge and clinical training at the University of Oxford, qualifying in 1997. His oncology training was based at the Royal Marsden, St George’s and Guy’s Hospitals, London. He gained his MD research degree in 2005 from the Institute of Cancer Research at the University of London. In 2008 he was appointed as Senior Lecturer in Oncology at Brighton and Sussex Medical School, where he held various roles including Director of the Brighton NIHR Clinical Research Facility. In 2014 he was appointed Consultant in Medical Oncology at the Royal Marsden Hospital.

He is a member of the National Cancer Research Institute (NCRI) Breast Clinical Studies Group, and chair of the NCRI Advanced Breast Cancer subgroup, which oversees trials for advanced breast cancer in the UK. He is a member of the American Society of Clinical Oncology. 

Dr Marina Parton is a Medical Oncologist in Breast Cancer at The Royal Marsden and Kingston Hospitals. Appointed to The Royal Marsden Consultant body in 2009, she received her oncology training at The Royal Marsden and carried out her research in neoadjuvant therapy in breast cancer as part of a MD at The Institute of Cancer Research at the University of London. 

Dr Parton is Lead Cancer Clinician in The Royal Marsden's

Discusses the impact of a diagnosis of early breast cancer.

Reviews the incidence of long-term complications as a result of treatment.

Provides practical advice for the healthcare professional